[{"Assets_0_Q3_USD":445337000.0,"CommonStockSharesOutstanding_0_Q3_shares":56762000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-173845000.0,"NetIncomeLoss_1_Q3_USD":-58431000.0,"NetIncomeLoss_3_Q3_USD":-170849000.0,"StockholdersEquity_0_Q3_USD":-182805000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":56690000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":56308000.0,"Ticker":"TBPH","CIK":"1583107","name":"THERAVANCE BIOPHARMA, INC.","OfficialName":"Theravance Biopharma Inc. Ordinary Shares","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"688048421.0","Country":"Cayman Islands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191108"}]